The price of medicines in Europe is in danger of reaching the heights and being similar or worse to the one in the US who cost “gold” because of Donald Trump. The US president is pushing for pharmaceuticals to reduce prices in America so that all Americans can access. But if that happens, the companies will pass the gap and in order to make the same profit they will increase prices elsewhere, namely in Europe, where their other big market is located, the FTs wrote. According to a Financial Times report in the United Kingdom, an “experiment” is ongoing. In the end of his first term, Trump pressed in that direction, but was prevented by the federal courts. It is now coming back heavier and so far exerts pressure on Britain -based pharmaceuticals. These companies allegedly pushed to accurately accurately in Britain to reduce the other side of the Atlantic. In the event of […]
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
